Combination immunotherapy and anti-angiogenic therapy shows promising efficacy in NSCLC patients with recurrent or refractory brain metastases and negative driver genes
Authors
Liwei Sun
Jinduo Li
Bonian Chen
Xiaomin Liu (ORCID: https://orcid.org/0000-0003-2021-2134)
Pengfei Liu (ORCID: https://orcid.org/0000-0003-3106-8481)
Bin Wang (ORCID: https://orcid.org/0000-0001-7771-5360)
Lin Li (ORCID: https://orcid.org/0000-0003-0426-6546)
Caijuan Tian
Hongbo Zhang
Institutions
Tianjin University of Traditional Chinese Medicine (CN)
Combination immunotherapy and anti-angiogenic therapy shows promising efficacy in NSCLC patients with recurrent or refractory brain metastases and negative driver genes
Liwei Sun, Jinduo Li, Bonian Chen, Xiaomin Liu et al.
Citations
1 citations
Journal
Frontiers in Immunology
Topics
Brain Metastases and Treatment
Field-Weighted Citation Impact (FWCI)
1.52
article
Combination immunotherapy and anti-angiogenic therapy shows promising efficacy in NSCLC patients with recurrent or refractory brain metastases and negative driver genes
Liwei Sun, Jinduo Li, Bonian Chen, Xiaomin Liu, Pengfei Liu, Bin Wang, Lin Li, Caijuan Tian, Hongbo Zhang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Tianjin University of Traditional Chinese Medicine (CN), Tianjin Huanhu Hospital (CN), Marvell (Israel) (IL)